These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 24879978)

  • 1. Genetic basis of drug-induced liver injury: present and future.
    Urban TJ; Daly AK; Aithal GP
    Semin Liver Dis; 2014 May; 34(2):123-33. PubMed ID: 24879978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are Polymorphisms in Genes Relevant to Drug Disposition Predictors of Susceptibility to Drug-Induced Liver Injury?
    Daly AK
    Pharm Res; 2017 Aug; 34(8):1564-1569. PubMed ID: 28028769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human leukocyte antigen genetic risk factors of drug-induced liver toxicology.
    Grove JI; Aithal GP
    Expert Opin Drug Metab Toxicol; 2015 Mar; 11(3):395-409. PubMed ID: 25491399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacogenomics in drug induced liver injury.
    Andrade RJ; Agúndez JA; Lucena MI; Martínez C; Cueto R; García-Martín E
    Curr Drug Metab; 2009 Nov; 10(9):956-70. PubMed ID: 20214588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced liver injury: past, present and future.
    Daly AK
    Pharmacogenomics; 2010 May; 11(5):607-11. PubMed ID: 20415545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacogenetic testing in idiosyncratic drug-induced liver injury: current role in clinical practice.
    Aithal GP
    Liver Int; 2015 Jul; 35(7):1801-8. PubMed ID: 25809692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic risk factors in the development of idiosyncratic drug-induced liver injury.
    Stephens C; Lucena MI; Andrade RJ
    Expert Opin Drug Metab Toxicol; 2021 Feb; 17(2):153-169. PubMed ID: 33222552
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic association studies in drug-induced liver injury.
    Daly AK; Day CP
    Drug Metab Rev; 2012 Feb; 44(1):116-26. PubMed ID: 21913872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-Wide Association Studies in Drug-Induced Liver Injury: Step Change in Understanding the Pathogenesis.
    Aithal GP; Grove JI
    Semin Liver Dis; 2015 Nov; 35(4):421-31. PubMed ID: 26676816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of drug-induced liver injury.
    Russmann S; Jetter A; Kullak-Ublick GA
    Hepatology; 2010 Aug; 52(2):748-61. PubMed ID: 20607838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-induced liver injury: insights from genetic studies.
    Andrade RJ; Robles M; Ulzurrun E; Lucena MI
    Pharmacogenomics; 2009 Sep; 10(9):1467-87. PubMed ID: 19761370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Predisposition to Drug-Induced Liver Injury.
    Stephens C; Andrade RJ
    Clin Liver Dis; 2020 Feb; 24(1):11-23. PubMed ID: 31753244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of drug-induced liver injury: Current knowledge and future prospects.
    Daly AK
    Clin Transl Sci; 2023 Jan; 16(1):37-42. PubMed ID: 36194091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Newly identified genetic variants associated with idiosyncratic drug-induced liver injury.
    Stolz A
    Curr Opin Gastroenterol; 2022 May; 38(3):230-238. PubMed ID: 35645018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of Oxidative Stress-Related Candidate Genes as Risk Factors for Drug-Induced Liver Injury due to Co-Amoxiclav.
    Alshabeeb MA; Aithal GP; Daly AK
    DNA Cell Biol; 2020 Mar; 39(3):349-354. PubMed ID: 31905014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver and Statins: A Critical Appraisal of the Evidence.
    Licata A; Giammanco A; Minissale MG; Pagano S; Petta S; Averna M
    Curr Med Chem; 2018; 25(42):5835-5846. PubMed ID: 29589533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injury.
    Kaniwa N; Saito Y
    J Hum Genet; 2013 Jun; 58(6):317-26. PubMed ID: 23635947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic association studies in drug-induced liver injury.
    Daly AK; Day CP
    Semin Liver Dis; 2009 Nov; 29(4):400-11. PubMed ID: 19826974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of isoniazid-induced idiosyncratic liver injury: emerging role of mitochondrial stress.
    Boelsterli UA; Lee KK
    J Gastroenterol Hepatol; 2014 Apr; 29(4):678-87. PubMed ID: 24783247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic polymorphisms of manganese superoxide dismutase, NAD(P)H:quinone oxidoreductase, glutathione S-transferase M1 and T1, and the susceptibility to drug-induced liver injury.
    Huang YS; Su WJ; Huang YH; Chen CY; Chang FY; Lin HC; Lee SD
    J Hepatol; 2007 Jul; 47(1):128-34. PubMed ID: 17400324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.